Stock 8158 CHINA REGENERATIVE MEDICINE INTERNATIONAL LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

News China Regenerative Medicine International Limited

Equities

8158

KYG2129W1380

Market Closed - Hong Kong S.E.
Other stock markets
 09:08:49 06/05/2024 BST 		5-day change 1st Jan Change
0.185 HKD +1.65% Intraday chart for China Regenerative Medicine International Limited -31.48% -66.36%
04-02 China Regenerative Medicine International Limited Reports Earnings Results for the Full Year Ended December 31, 2023 CI
2023 China Regenerative Medicine International Limited Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
China Regenerative Medicine International Limited Reports Earnings Results for the Full Year Ended December 31, 2023
CI
China Regenerative Medicine International Limited Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
CI
China Regenerative Medicine International Limited Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
CI
China Regenerative Medicine International Limited Reports Earnings Results for the First Quarter Ended March 31, 2023
CI
China Regenerative Medicine International Limited Reports Earnings Results for the Full Year Ended December 31, 2022
CI
China Regenerative Medicine International Limited Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022
CI
China Regenerative Medicine International Limited Announces CFO Change
CI
China Regenerative Medicine International Limited Announces Executive Changes
CI
China Regenerative Medicine International Limited Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
CI
China Regenerative Medicine International Limited Reports Earnings Results for the First Quarter Ended March 31, 2022
CI
China Regenerative Medicine International Limited Reports Earnings Results for the Full Year Ended December 31, 2021
CI
China Regenerative Medicine International Limited Announces Delay in Publication of Audited Annual Results for the Year Ended 31 December 2021
CI
China Regenerative Medicine International Limited Announces Board Changes
CI
China Regenerative Medicine International Limited Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021
CI
China Regenerative Medicine International Limited Announces Executive Changes
CI
China Regenerative Medicine International Limited Reports Earnings Results for the Second Quarter Ended June 30, 2021
CI
China Regenerative Medicine International Limited Announces the Cessation of Lee Pak Chung as Chief Financial Officer
CI
China Regenerative Medicine International Limited Reports Earnings Results for the First Quarter Ended March 31, 2021
CI
China Regenerative Medicine International Limited Reports Earnings Results for the Full Year Ended December 31, 2020
CI
China Regenerative Medicine International Limited Enters into Non-Legally Binding Memorandum of Understanding with Jinxin Holdings Co, Ltd
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. 8158 Stock
  4. News China Regenerative Medicine International Limited